Meta-Analysis of the Effect of Telemonitoring on Blood Sugar Levels and Quality of Life in Diabetes Patients
Abstract
Background: Type 2 diabetes mellitus (DM), a chronic disease, requires continuous monitoring and treatment to have a better quality of life. Telemonitoring is a medium that may help in monitoring patients with type 2 DM. This study aimed to analyze the effect of using telemonitoring on blood sugar levels and quality of life of patients with type 2 DM with a meta-analysis study.
Subjects and Method: This was a systematic review and meta-analysis conducted with PRISMA flow diagram. The articles were collected through journal databases, including PubMed, Google Scholar, Science Direct, and ProQuest, published in 2000-2021. The keywords used were ("telemedicine" OR "tele-monitoring" OR "tele-monitoring") AND ("diabetes" OR "diabetes mellitus" OR "diabetes mellitus type 2") AND ("glucose level") AND ("quality of life"). The searching of articles used the PICO model. Population: people with type 2 diabetes mellitus, Intervention: telemonitoring, Comparison: not using telemonitoring, Outcome: blood sugar level and quality of life. Inclusion criteria were full-text articles with Randomized Controlled Trial (RCT) study design, published in English, with the effect measure of Mean SD. Eligible articles were analyzed using Revman 5.3.
Results: A meta-analysis of 11 primary studies on the use of telemonitoring of blood sugar level showed a decrease in blood sugar (HbA1c) levels in patients with type 2 diabetes by 0.20 times compared to not using telemonitoring (SMD= -0.20; 95% CI= -0.39 to -0.01; p= 0.040). A meta-analysis of 6 primary studies on the use of telemonitoring on quality of life showed an increase in quality of life in type 2 diabetes patients by 0.16 times compared to not using telemonitoring (SMD= -0.16; 95% CI= -0.29 to -0.03; p= 0.020).
Conclusion: Telemonitoring can improve blood sugar levels and the quality of life of patients with type 2 diabetes.
Keywords: telemonitoring, type 2 diabetes mellitus, quality of life, meta-analysis
Correspondence: Anisa Asri Sholihah. Masters Program in Public Health, Universitas Sebelas Maret. Jl. Ir. Sutami 36A, Surakarta 57126, Central Java. Email: anisaasri92@gmail.com. Mobile: 085740972908.
Indonesian Journal of Medicine (2021), 06(03): 246-257
https://doi.org/10.26911/theijmed.2021.06.03.02
References
Andrès E, Meyer L, Zulfikar AA, Hajjam M, Talha S, Ervè S, Hajjam J, et al. (2019). Current researches on telemonitoring in patients with diabetes mellitus: A short pragmatic narrative review. Trends Telemed E-Health. 1(3). TTEH.000513. http://dx.doi.org/10.31031/TTEH.2019.01.000513.
Abdul M, Hashim MJ, King JK, Govender RD, Mustafa H, Kaabi JA (2020). Epidemiology of type 2 diabetes global burden of disease and forecasted trends. J Epidemiol Glob Health. 10(1): 107-111. https://doi.org/10.2991/jegh.k.191028.001.
Boaz M, Hellman K, Wainstein J (2009).An automated telemedicine system improves patient-reported wellbeing. Diabetes Technol Ther. 11(3): 181–186. doi: 10.1089/dia.2008.0048.
Carr J, Gibson B, Robinson P (2001). Implications for measuring quality of life. Bmj. 322: 1240–3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1120338/pdf/1240.pdf.
Cho JH, Kwon HS, Kim HS, Oh JA, Yoon KH (2011). Effects on diabetes management of a health-care provider mediated, remote coaching system via a PDA-type glucometer and the Internet. J Telemed. 17(7): 365–370. doi: 10.1258/jtt.2011.100913.
Dario C, Toffani R, Calcaterra F, Saccavini C, Stafylas P, Mancin S, Vio E (2017). Telemonitoring of type 2 diabetes mellitus in Italy. Telemed J e-Health. 23(2): 143–152. doi: 10.1089/tmj.20-15.0224.
González-Molero I, Domínguez-López M, Guerrero M, Carreira M, Caballero Felix, Rubio-Martín E, Linares Fet al. (2012). Use of telemedicine in subjects with type 1 diabetes equipped with an insulin pump and real-time continuous glucose monitoring. J Telemed. 18(6): 328–332. doi: 10.1258/jtt.2012.120103.
IDF (2019). Diabetes prevalence, International Diabetes Federation (IDF). Available at: https://diabetesatlas.org/en/sections/demographic-and-geographic-outline.html.
Klonoff DC, Ahn D, Drincic A (2017). Continuous glucose monitoring: A review of the technology and clinical use. Diabetes Res Clin Pract. 133: 178-192. https://doi.org/10.1016/j.diabres.2017.08.005.
Kopp M, Steinlechner M, Ruedl G, Ledo-chowski L, Rumpold G, Taylor AH, et al. (2012). Acute effects of brisk walking on affect and psychological wellbeing in individuals with type 2 diabetes.Diabetes Res Clin Pract. El-sevier Ireland Ltd. 95(1):25–29. doi: 10.1016/j.diabres.2011.09.017.
Murti, B. (2018). Prinsip dan Metode Riset Epidemiologi (Edisi V) (Epidemiological Research Principles and Methods (V Edition)). Edisi V. Surakarta: Bintang Fajar Offset.
Nicolucci A, Cercone S, Chiriatti A, Muscas F, Gensini G, Fucito G, Gambini A, et al. (2015). A randomized trial on home telemonitoring for the management of metabolic and cardiovascular risk in patients with type 2 diabetes. Diabetes Technol Ther. 17(8):563–570. doi: 10.1089/dia.2014.0355.
Paré G, Jaana M, Sicotte C (2007). Systematic review of home telemonitoring for chronic diseases: The evidence base. J Am Med Inform Assoc. 14(3): 269–277. doi: 10.1197/jamia.M2270.
Paré Guy, Moqadem K, Pineau G, St-Hilaire C (2010). Clinical effects of home telemonitoring in the context of diabetes, asthma, heart failure and hypertension: A systematic review. J Med Internet Res. 12(2). doi: 10.2196-/jmir.1357.
Pecina JL, Hanson GJ, Van Houten H, Takahashi PY, et al. (2013). Impact of telemonitoring on older adults health-related quality of life: The Tele-ERA study. Qual Life Res. 22(9): 2315–2321. doi: 10.1007/s11136-013-0361-5.
Petersmann A, Nauck M, Müller-Wieland D, Kerner W, Müller UA, Landgraf R, Freckmann G, et al. (2018). Definition, Classification and Diagnosis of Diabetes Mellitus. Exp Clin Endocrinol Diabetes. 126(7)
:406–410. doi: 10.1055/a-0584-6223.
Riskesdas (2018). Hasil Utama Riset Kese-hatan Dasar (Main Results of Basic Health Research).Kementrian Kesehatan Republik Indonesia: 1–100. Accessed: 1 Desember 2013.
Rudel D, Fisk M, Roze R (2011). Definitions of Terms in Telehealth. Infor Med Slov. 16(1): 28-46. http://ims.mf.unilj.si/archive/16(1)/21.pdf.
Solli O, Stavem K, Kristiansen IS (2010). Health-related quality of life in diabetes: The associations of complications with EQ-5D scores. Health Qual Life Outcomes. 8: 18. https://doi.org/10.1186/1477-7525-8-18.
Valdivieso B, García-Sempere A, Sanfélix-Gimeno G, Faubel R, Librero J, Soriano E, Peiró S, et al. (2018). The effect of telehealth, telephone support or usual care on quality of life, mortality and healthcare utilization in elderly high-risk patients with multiple chronic conditions. A prospective study. Med Clin (Barc). 151(8):308–314. https://doi.org/10.1016/j.medcli-.2018.03.013.
Waki K, Fujita H, Uchimura Y, Omae K, Aramaki E, Kato S, Lee H, et al. (2014). DialBetics: A novel smartphone-based self-management support system for type 2 diabetes patients. J Diabetes Sci Technol. 8(2): 209–215. doi: 10.1177/193229681-4526495.
WHO (2020). Non-communicable diseases. Available at: https://www.who.int/news-room/fact-sheets/detail/non-communicable-diseases.
WHO (2020). Diabetes. Available at: https://www.who.int/news-room/fact-sheets/detail/diabetes.
Warren R, Carlisle K, Mihala G, Scuffham PA (2017). Effects of telemonitoring on glycaemic control and healthcare costs in type 2 diabetes: A randomized controlled trial. 0(0):1–10. doi: 10.1177 1357633X17723943
Wild SH, Hanley J, Lewis SC, McKnight JA, Padfield PL, et al. (2016). Supported telemonitoring and glycemic control in people with type 2 diabetes: The telescot diabetes pragmatic multicenter randomized controlled trial. PLoS Medicine. 13(7): 1–16. doi: 10.1371/journal.pmed.1002098.
